Lucid Diagnostics Inc. Management Fee Expense
Lucid Diagnostics Inc. (LUCD) reported Management Fee Expense of $3.15 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ManagementFeeExpense · last filed 2025-11-12
- Lucid Diagnostics Inc. management fee expense for the quarter ending 2025-09-30 was $3.15M, a 26.00% increase year-over-year.
- Lucid Diagnostics Inc. management fee expense for the quarter ending 2025-06-30 was $3.15M, a 26.00% increase year-over-year.
- Lucid Diagnostics Inc. management fee expense for the quarter ending 2025-03-31 was $3.15M, a 26.00% increase year-over-year.
- Lucid Diagnostics Inc. management fee expense for the quarter ending 2024-12-31 was $3.15M, a 40.00% increase year-over-year.
- Lucid Diagnostics Inc. management fee expense for fiscal 2024 was $11.30M, a 25.56% increase from fiscal 2023.
- Lucid Diagnostics Inc. management fee expense for fiscal 2023 was $9.00M.
| Period end | Management Fee Expense 3 month | Management Fee Expense 6 month | Management Fee Expense 9 month | Management Fee Expense 12 month |
|---|---|---|---|---|
| 2025-09-30 | $3.15M 10-Q · filed 2025-11-12 | $6.30M derived: sum of 2 quarters · filed 2025-11-12 | $9.45M 10-Q · filed 2025-11-12 | $12.60M derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | $3.15M 10-Q · filed 2025-08-12 | $6.30M 10-Q · filed 2025-08-12 | $9.45M derived: sum of 3 quarters · filed 2025-08-12 | $11.95M derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-03-31 | $3.15M 10-Q · filed 2025-05-13 | $6.30M derived: sum of 2 quarters · filed 2025-05-13 | $8.80M derived: sum of 3 quarters · filed 2025-11-12 | $11.30M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-12-31 | $3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $5.65M derived: sum of 2 quarters · filed 2025-11-12 | $8.15M derived: sum of 3 quarters · filed 2025-11-12 | $11.30M 10-K · filed 2025-03-24 |
| 2024-09-30 | $2.50M 10-Q · filed 2025-11-12 | $5.00M derived: sum of 2 quarters · filed 2025-11-12 | $8.15M 10-Q · filed 2025-11-12 | $9.75M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $2.50M 10-Q · filed 2025-08-12 | $5.00M 10-Q · filed 2025-08-12 | $7.25M derived: sum of 3 quarters · filed 2025-08-12 | |
| 2024-03-31 | $2.50M 10-Q · filed 2024-05-13 | $4.75M derived: sum of 2 quarters · filed 2025-03-24 | ||
| 2023-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $9.00M 10-K · filed 2025-03-24 | ||
| 2023-09-30 | $6.75M 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |